Product Ref: PFALZ01 Category: A
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
Category | POM-V |
Temperature | Ambient |
MA/VM/EU No: | 31592/4003 |
Species |
|
VMD Link | https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_279420.PDF |
NOAH Link | |
Dosage | Amounts to be administered and administration route . For single intramuscular use. The dose depends on the previously administered medetomidine or dexmedetomidine dose. Use of an appropriately graduated syringe is recommended to ensure accurate dosing when administering small volumes. Atipamezole is generally administered 15-60 minutes after medetomidine or dexmedetomidine injection. Dogs: The dose of atipamezole hydrochloride (in µg per kg of bodyweight) is five times that of the previous dose of medetomidine hydrochloride or ten times that of the dose of dexmedetomidine hydrochloride. Due to the fivefold concentration of the active ingredient (atipamezole hydrochloride) in this product compared to that of preparations containing 1 mg medetomidine hydrochloride per ml and the tenfold concentration compared to that of preparations containing 0.5 mg dexmedetomidine hydrochloride, an equal volume of each preparation is required. Due to the 50-fold concentration compared to that preparations containing 0.1 mg dexmedetomidine hydrochloride, a volume 5 times lower of the atipamezole preparation is required. Dosage example dogs: Medetomidine 1.0 mg/ml solution for injection dosage Atipamezole hydrochloride 5.0 mg/ml solution for injection dosage 0.04 ml/kg body weight (bw), corresponding with 40 μg/kg bw 0.04 ml/kg body weight (bw), corresponding with 200 μg/kg bw Dexmedetomidine 0.5 mg/ml solution for injection dosage Atipamezole hydrochloride 5.0 mg/ml solution for injection dosage 0.04 ml/kg body weight (bw), corresponding with 20 μg/kg bw 0.04 ml/kg body weight (bw), corresponding with 200 μg/kg bw Dexmedetomidine 0.1 mg/ml solution for injection dosage Atipamezole hydrochloride 5.0 mg/ml solution for injection dosage 0.2 ml/kg body weight (bw), corresponding with 20 μg/kg bw 0.04 ml/kg body weight (bw), corresponding with 200 μg/kg bw Cats: The atipamezole hydrochloride dose (in µg per kg of bodyweight) is 2.5 times that of the previous dose of medetomidine hydrochloride or five times that of the dose of dexmedetomidine hydrochloride. Due to the fivefold concentration of the active ingredient (atipamezole hydrochloride) in this product compared to that of preparations containing 1 mg medetomidine hydrochloride per ml and the tenfold concentration compared to that of preparations containing 0.5 mg dexmedetomidine hydrochloride, half the volume of the product to that of the previously administered medetomidine or dexmedetomidine should be given. Due to the 50-fold concentration compared to that preparations containing 0.1 mg dexmedetomidine hydrochloride, a volume 10 times lower of the atipamezole preparation is required. Dosage example cats: Medetomidine 1.0 mg/ml solution for injection dosage Atipamezole hydrochloride 5.0 mg/ml solution for injection dosage 0.08 ml/kg body weight (bw), corresponding with 80 μg/kg bw 0.04 ml/kg body weight (bw), corresponding with 200 μg/kg bw Dexmedetomidine 0.5 mg/ml solution for injection dosage Atipamezole hydrochloride 5.0 mg/ml solution for injection dosage 0.08 ml/kg body weight (bw), corresponding with 40 μg/kg bw 0.04 ml/kg body weight (bw), corresponding with 200 μg/kg bw Dexmedetomidine 0.1 mg/ml solution for injection dosage Atipamezole hydrochloride 5.0 mg/ml solution for injection dosage 0.4 ml/kg body weight (bw), corresponding with 40 μg/kg bw 0.04 ml/kg body weight (bw), corresponding with 200 μg/kg bw The recovery time for dogs and cats is shortened to approximately 5 minutes. The animals become mobile after approximately 10 minutes after administration of the product. 4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary Overdose of atipamezole hydrochloride may result in transient tachycardia and over-alertness (hyperactivity, muscle tremor). If necessary, these signs may be reversed by a medetomidine or dexmedetomidine hydrochloride dose which is lower than usually used clinically. If atipamezole hydrochloride is inadvertently administered to an animal not previously treated with medetomidine or dexmedetomidine hydrochloride, hyperactivity and muscle tremor may occur. These effects may persist for about 15 minutes. Over-alertness in the cat is best handled by minimizing external stimuli. |
Withdrawals |